Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Biosante Pharmaceuticals Inc BPAX

Healthcare Biotechnology

NDAQ:BPAX - Post Discussion

Biosante Pharmaceuticals Inc > Excellent and Risky Opportunity
View:
Post by vforvalue on Jun 20, 2008 1:06pm

Excellent and Risky Opportunity

BPAX is testing out one of its newest bio drug LibiGel, a testosterone gel intended to restore loss of sexual desire in women. BPAX has a ton of cash but the drug is still on trial and might not be approved. Nevertheless, there are some major buy out opportunities! If you are a risky investor and believe this drug will succeed just like BPAX's Elestrin drug did, then this opportunity is right for you!

more on this news is found on this interesting article here:
https://www.stockhouse.com//Columnists/2008/June/16/Biopharma-an-attractive-M-A-target-for-large-drug-
Comment by basement1 on Jun 20, 2008 2:29pm
Nice to know there is someone else out there interested in this company!!!
Comment by gossipgirl on Jun 20, 2008 10:18pm
BioSante Pharmaceuticals seems to be a great opportunity if you're interested in investing in a biopharma. It is already in great financial position with no debt and tons of cash. If all goes well, the company is said to file for a new-drug application in late 2009 and launched by 2011.Although it is risky since LibiGel has not yet been approved, it shows a lot of promise since it addresses a ...more  
Comment by amy89 on Jun 21, 2008 3:15pm
I would like to see some testing numbers for this product. How well does it work, and generally what phase it is in its trials. If it were to approved and presuming it would actually work, it would make a decent amount of capital. Particularly if it was marketed well enough. Now I think one would have to wait on a long term scale to see any income from this stock, as I doubt the product would be ...more  
Biosante Pharmaceuticals Inc